Home / Inspections / 1011451

FDA Inspection 1011451 — Northwind Pharmaceuticals LLC

Northwind Pharmaceuticals LLC — FEI 1831143

The FDA completed an inspection of Northwind Pharmaceuticals LLC on March 13, 2017 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 13, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)

Facility

Other inspections at this facility

  • 1256379 (VAI Fri Sep 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073148 (VAI Fri Nov 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 952157 (OAI Wed Dec 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944649 (VAI Mon Sep 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 900116 (NAI Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources